Copyright Reports & Markets. All rights reserved.

Global Intravenous (IV) Solution Market Research Report 2021

Request for Sample of this report
Buy now

1 Intravenous (IV) Solution Market Overview

  • 1.1 Product Overview and Scope of Intravenous (IV) Solution
  • 1.2 Intravenous (IV) Solution Segment by Type
    • 1.2.1 Global Intravenous (IV) Solution Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Total Parenteral Solution
    • 1.2.3 Peripheral Parenteral Solution
  • 1.3 Intravenous (IV) Solution Segment by Application
    • 1.3.1 Intravenous (IV) Solution Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospitals & Clinics
    • 1.3.3 Ambulatory
    • 1.3.4 Homecare
  • 1.4 Global Intravenous (IV) Solution Market Size Estimates and Forecasts
    • 1.4.1 Global Intravenous (IV) Solution Revenue 2016-2027
    • 1.4.2 Global Intravenous (IV) Solution Sales 2016-2027
    • 1.4.3 Intravenous (IV) Solution Market Size by Region: 2016 Versus 2021 Versus 2027

2 Intravenous (IV) Solution Market Competition by Manufacturers

  • 2.1 Global Intravenous (IV) Solution Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Intravenous (IV) Solution Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Intravenous (IV) Solution Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Intravenous (IV) Solution Manufacturing Sites, Area Served, Product Type
  • 2.5 Intravenous (IV) Solution Market Competitive Situation and Trends
    • 2.5.1 Intravenous (IV) Solution Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Intravenous (IV) Solution Players Market Share by Revenue
    • 2.5.3 Global Intravenous (IV) Solution Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Intravenous (IV) Solution Retrospective Market Scenario by Region

  • 3.1 Global Intravenous (IV) Solution Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Intravenous (IV) Solution Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Intravenous (IV) Solution Market Facts & Figures by Country
    • 3.3.1 North America Intravenous (IV) Solution Sales by Country
    • 3.3.2 North America Intravenous (IV) Solution Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Intravenous (IV) Solution Market Facts & Figures by Country
    • 3.4.1 Europe Intravenous (IV) Solution Sales by Country
    • 3.4.2 Europe Intravenous (IV) Solution Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Intravenous (IV) Solution Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Intravenous (IV) Solution Sales by Region
    • 3.5.2 Asia Pacific Intravenous (IV) Solution Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Intravenous (IV) Solution Market Facts & Figures by Country
    • 3.6.1 Latin America Intravenous (IV) Solution Sales by Country
    • 3.6.2 Latin America Intravenous (IV) Solution Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Intravenous (IV) Solution Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Intravenous (IV) Solution Sales by Country
    • 3.7.2 Middle East and Africa Intravenous (IV) Solution Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 U.A.E

4 Global Intravenous (IV) Solution Historic Market Analysis by Type

  • 4.1 Global Intravenous (IV) Solution Sales Market Share by Type (2016-2021)
  • 4.2 Global Intravenous (IV) Solution Revenue Market Share by Type (2016-2021)
  • 4.3 Global Intravenous (IV) Solution Price by Type (2016-2021)

5 Global Intravenous (IV) Solution Historic Market Analysis by Application

  • 5.1 Global Intravenous (IV) Solution Sales Market Share by Application (2016-2021)
  • 5.2 Global Intravenous (IV) Solution Revenue Market Share by Application (2016-2021)
  • 5.3 Global Intravenous (IV) Solution Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 ICU Medical
    • 6.1.1 ICU Medical Corporation Information
    • 6.1.2 ICU Medical Description and Business Overview
    • 6.1.3 ICU Medical Intravenous (IV) Solution Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 ICU Medical Product Portfolio
    • 6.1.5 ICU Medical Recent Developments/Updates
  • 6.2 B. Braun Melsungen
    • 6.2.1 B. Braun Melsungen Corporation Information
    • 6.2.2 B. Braun Melsungen Description and Business Overview
    • 6.2.3 B. Braun Melsungen Intravenous (IV) Solution Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 B. Braun Melsungen Product Portfolio
    • 6.2.5 B. Braun Melsungen Recent Developments/Updates
  • 6.3 Fresenius Kabi
    • 6.3.1 Fresenius Kabi Corporation Information
    • 6.3.2 Fresenius Kabi Description and Business Overview
    • 6.3.3 Fresenius Kabi Intravenous (IV) Solution Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Fresenius Kabi Product Portfolio
    • 6.3.5 Fresenius Kabi Recent Developments/Updates
  • 6.4 Baxter
    • 6.4.1 Baxter Corporation Information
    • 6.4.2 Baxter Description and Business Overview
    • 6.4.3 Baxter Intravenous (IV) Solution Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Baxter Product Portfolio
    • 6.4.5 Baxter Recent Developments/Updates
  • 6.5 Amanta Healthcare
    • 6.5.1 Amanta Healthcare Corporation Information
    • 6.5.2 Amanta Healthcare Description and Business Overview
    • 6.5.3 Amanta Healthcare Intravenous (IV) Solution Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Amanta Healthcare Product Portfolio
    • 6.5.5 Amanta Healthcare Recent Developments/Updates
  • 6.6 Terumo Medical Corporation
    • 6.6.1 Terumo Medical Corporation Corporation Information
    • 6.6.2 Terumo Medical Corporation Description and Business Overview
    • 6.6.3 Terumo Medical Corporation Intravenous (IV) Solution Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Terumo Medical Corporation Product Portfolio
    • 6.6.5 Terumo Medical Corporation Recent Developments/Updates
  • 6.7 Grifols
    • 6.6.1 Grifols Corporation Information
    • 6.6.2 Grifols Description and Business Overview
    • 6.6.3 Grifols Intravenous (IV) Solution Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Grifols Product Portfolio
    • 6.7.5 Grifols Recent Developments/Updates

7 Intravenous (IV) Solution Manufacturing Cost Analysis

  • 7.1 Intravenous (IV) Solution Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Intravenous (IV) Solution
  • 7.4 Intravenous (IV) Solution Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Intravenous (IV) Solution Distributors List
  • 8.3 Intravenous (IV) Solution Customers

9 Intravenous (IV) Solution Market Dynamics

  • 9.1 Intravenous (IV) Solution Industry Trends
  • 9.2 Intravenous (IV) Solution Growth Drivers
  • 9.3 Intravenous (IV) Solution Market Challenges
  • 9.4 Intravenous (IV) Solution Market Restraints

10 Global Market Forecast

  • 10.1 Intravenous (IV) Solution Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Intravenous (IV) Solution by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Intravenous (IV) Solution by Type (2022-2027)
  • 10.2 Intravenous (IV) Solution Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Intravenous (IV) Solution by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Intravenous (IV) Solution by Application (2022-2027)
  • 10.3 Intravenous (IV) Solution Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Intravenous (IV) Solution by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Intravenous (IV) Solution by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Total Parenteral Solution
    Peripheral Parenteral Solution

    Segment by Application
    Hospitals & Clinics
    Ambulatory
    Homecare

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    U.A.E

    By Company
    ICU Medical
    B. Braun Melsungen
    Fresenius Kabi
    Baxter
    Amanta Healthcare
    Terumo Medical Corporation
    Grifols

    Buy now